Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2007, Pages 482-488

  Debaun, Michael R ^a   Field, Joshua J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL ANEMIA; STROKE;

ANEMIA, SICKLE CELL; HUMANS; HYDROXYUREA; MULTICENTER STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 49349099103     PISSN: 15204391     EISSN: None     Source Type: Journal    
DOI: 10.1182/asheducation-2007.1.482     Document Type: Article

References (0)